Teniposide 50 mg/5 mL (10 mg/mL vial) Suppliers & Bulk Manufacturers
Available Forms: Injection (IV)
Available Strengths: 50 mg/5 mL (10 mg/mL vial)
Reference Brands: Vumon® (EU & US)
Category: Oncology Cancer Care
Teniposide is a topoisomerase II inhibitor used in oncology, primarily for treating acute lymphoblastic leukemia (ALL) in pediatric patients. Marketed under the brand name Vumon®, it is available in 50 mg/5 mL (10 mg/mL) IV vials in both the US and EU. Teniposide is a critical component in combination chemotherapy protocols and is supplied under GMP-compliant manufacturing. Ideal for pharma B2B partners, Teniposide supports trusted oncology supply chains across regulated markets.
Product Description: Teniposide Injection is a potent chemotherapeutic agent used in the treatment of acute lymphoblastic leukemia (ALL), especially in pediatric patients with relapsed or refractory disease. Classified as a topoisomerase II inhibitor, Teniposide disrupts DNA replication and cell division, making it effective in oncology protocols. It is commercially available in the US and EU under the brand name Vumon®, typically in 50 mg/5 mL (10 mg/mL) injectable vials. Teniposide is manufactured under strict GMP standards, making it ideal for B2B pharmaceutical distributors, hospital tenders, and global supply chains seeking reliable oncology solutions in regulated markets.
Teniposide — third party manufacturing & bulk supply
Teniposide 50 mg/5 mL (10 mg/mL vial) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Teniposide is supplied as Injection (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Teniposide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Teniposide →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
